Exonic variants associated with development of aspirin exacerbated respiratory diseases

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Shin, Seung Woo ^a   Park, Byung Lae ^b   Chang, HunSoo ^a   Park, Jong Sook ^a   Bae, Da Jeong ^a   Song, Hyun Ji ^a   Choi, Inseon S ^c   Kim, Mi Kyeong ^d   Park, Hea Sim ^e   Kim, Lyoung Hyo ^b,f   Namgoong, Suhg ^b,f   Kim, Ji On ^b,f   Shin, Hyoung Doo ^b,f   Park, Choon Sik ^a  

^a Soonchunhyang University   (South Korea)

^b SNP Genetics Inc   (South Korea)

^c Chonnam National University Medical School   (South Korea)

^d Chungbuk National University   (South Korea)

^e Ajou University Medical CentSuwon   (South Korea)

^f Sogang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DNA DETERMINATION; EXOME; FEMALE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC MODEL; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN FUNCTION; PROTEIN STRUCTURE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; ASTHMA, ASPIRIN-INDUCED; DISEASE COURSE; EXON; GENETICS; GENOTYPE; MIDDLE AGED; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ASTHMA, ASPIRIN-INDUCED; DISEASE PROGRESSION; EXONS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; ROC CURVE; YOUNG ADULT;

EID: 84909990979     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111887     Document Type: Article

References (54)

1. Lee RU, Stevenson DD (2011) Aspirin-exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res 3: 3-10.
2. Szczeklik A, Nizankowska E, Duplaga M (2000) Natural history of aspirininduced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 16: 432-436.
3. Hedman J, Kaprio J, Poussa T, Nieminen MM (1999) Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 28: 717-722.
4. Sanak M, Pierzchalska M, Bazan-Socha S, Szczeklik A (2000) Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. Am J Respir Cell Mol Biol 23: 290-296.
5. Choi JH, Park HS, Oh HB, Lee JH, Suh YJ, et al. (2004) Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase. Hum Genet 114: 337-344.
6. Kim SH, Oh JM, Kim YS, Palmer LJ, Suh CH, et al. (2006) Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirinintolerant asthma in males. Clin Exp Allergy 36: 433-439.
7. Park JS, Chang HS, Park CS, Lee JH, Lee YM, et al. (2005) Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics. Pharmacogenet Genomics 15: 483-492.
8. Jinnai N, Sakagami T, Sekigawa T, Kakihara M, Nakajima T, et al. (2004) Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach. Hum Mol Genet 13: 3203-3217.
9. Kim SH, Kim YK, Park HW, Jee YK, Bahn JW, et al. (2007) Association between polymorphisms in prostanoid receptor genes and aspirin-intolerant asthma. Pharmacogenet Genomics 17: 295-304.
10. Park BL, Park SM, Park JS, Uh ST, Choi JS, et al. (2010) Association of PTGER gene family polymorphisms with aspirin intolerant asthma in Korean asthmatics. BMB Rep 43: 445-449.
11. Oh SH, Kim YH, Park SM, Cho SH, Park JS, et al. (2011) Association analysis of thromboxane A synthase 1 gene polymorphisms with aspirin intolerance in asthmatic patients. Pharmacogenomics 12: 351-363.
12. Kim SH, Choi JH, Park HS, Holloway JW, Lee SK, et al. (2005) Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma. Clin Exp Allergy 35: 585-590.
13. Dekker JW, Nizankowska E, Schmitz-Schumann M, Pile K, Bochenek G, et al. (1997) Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes. Clin Exp Allergy 27: 574-577.
14. Kim BS, Park SM, Uhm TG, Kang JH, Park JS, et al. (2010) Effect of single nucleotide polymorphisms within the interleukin-4 promoter on aspirin intolerance in asthmatics and interleukin-4 promoter activity. Pharmacogenet Genomics 20: 748-758.
15. Akahoshi M, Obara K, Hirota T, Matsuda A, Hasegawa K, et al. (2005) Functional promoter polymorphism in the TBX21 gene associated with aspirininduced asthma. Hum Genet 117: 16-26.
16. Kim SH, Bae JS, Holloway JW, Lee JT, Suh CH, et al. (2006) A polymorphism of MS4A2 (-109T〉C) encoding the beta-chain of the high-affinity immunoglobulin E receptor (FcepsilonR1beta) is associated with a susceptibility to aspirin-intolerant asthma. Clin Exp Allergy 36: 877-883.
17. Palikhe NS, Kim SH, Cho BY, Ye YM, Hur GY, et al. (2008) Association of three sets of high-affinity IgE receptor (FcepsilonR1) polymorphisms with aspirin-intolerant asthma. Respir Med 102: 1132-1139.
18. Palikhe NS, Kim SH, Kim JH, Losol P, Ye YM, et al. (2011) Role of Toll-like Receptor 3 Variants in Aspirin-Exacerbated Respiratory Disease. Allergy Asthma Immunol Res 3: 123-127.
19. Hitomi Y, Ebisawa M, Tomikawa M, Imai T, Komata T, et al. (2009) Associations of functional NLRP3 polymorphisms with susceptibility to foodinduced anaphylaxis and aspirin-induced asthma. J Allergy Clin Immunol 124: 779-785 e776.
20. Sakagami T, Jinnai N, Nakajima T, Sekigawa T, Hasegawa T, et al. (2007) ADAM33 polymorphisms are associated with aspirin-intolerant asthma in the Japanese population. J Hum Genet 52: 66-72.
21. Kim SH, Kim YK, Park HW, Ye YM, Min KU, et al. (2009) Adenosine deaminase and adenosine receptor polymorphisms in aspirin-intolerant asthma. Respir Med 103: 356-363.
22. Kim TH, Chang HS, Park SM, Nam BY, Park JS, et al. (2008) Association of angiotensin I-converting enzyme gene polymorphisms with aspirin intolerance in asthmatics. Clin Exp Allergy 38: 1727-1737.
23. Palikhe NS, Kim SH, Cho BY, Ye YM, Choi GS, et al. (2010) Genetic variability in CRTH2 polymorphism increases eotaxin-2 levels in patients with aspirin exacerbated respiratory disease. Allergy 65: 338-346.
24. Oh SH, Park SM, Park JS, Jang AS, Lee YM, et al. (2009) Association analysis of peroxisome proliferator-activated receptors gamma gene polymorphisms with asprin hypersensitivity in asthmatics. Allergy Asthma Immunol Res 1: 30-35.
25. Kim JH, Cha JY, Cheong HS, Park JS, Jang AS, et al. (2011) KIF3A, a cilia structural gene on chromosome 5q31, and its polymorphisms show an association with aspirin hypersensitivity in asthma. J Clin Immunol 31: 112-121.
26. Pasaje CF, Kim JH, Park BL, Cheong HS, Chun JY, et al. (2010) Association of SLC6A12 variants with aspirin-intolerant asthma in a Korean population. Ann Hum Genet 74: 326-334.
27. Park TJ, Kim JH, Bae JS, Park BL, Cheong HS, et al. (2011) Possible association of SLC22A2 polymorphisms with aspirin-intolerant asthma. Int Arch Allergy Immunol 155: 395-402.
28. Lee JS, Kim JH, Bae JS, Kim JY, Park TJ, et al. (2010) Association of CACNG6 polymorphisms with aspirin-intolerance asthmatics in a Korean population. BMC Med Genet 11: 138.
29. Park S-M, Park JS, Park H-S, Park C-S (2013) Unraveling the Genetic Basis of Aspirin Hypersensitivity in Asthma Beyond Arachidonate Pathways. Allergy Asthma Immunol Res 5.
30. Kim JH, Park BL, Cheong HS, Bae JS, Park JS, et al. (2010) Genome-wide and follow-up studies identify CEP68 gene variants associated with risk of aspirinintolerant asthma. PLoS One 5: e13818.
31. Park BL, Kim TH, Kim JH, Bae JS, Pasaje CF, et al. (2013) Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean population. Hum Genet 132: 313-321.
32. Pritchard JK (2001) Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 69: 124-137.
33. McCarthy MI, Hirschhorn JN (2008) Genome-wide association studies: potential next steps on a genetic journey. Hum Mol Genet 17: R156-165.
34. Illumina website (datasheet-humanexome-beadchips). Available: http://res. illumina.com/documents/products/datasheets/datasheet-humanexome- beadchips.pdf. Accessed 2014 Oct 13.
35. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, et al. (2008) Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31: 143-178.
36. Chang HS, Park JS, Jang AS, Park SW, Uh ST, et al. (2011) Diagnostic value of clinical parameters in the prediction of aspirin-exacerbated respiratory disease in asthma. Allergy Asthma Immunol Res 3: 256-264.
37. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczynska M, Picado C, et al. (2007) EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 62: 1111-1118.
38. Wang P, Dai M, Xuan W, McEachin RC, Jackson AU, et al. (2006) SNP Function Portal: a web database for exploring the function implication of SNP alleles. Bioinformatics 22: e523-529.
39. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, et al. (2010) A method and server for predicting damaging missense mutations. Nat Methods 7: 248-249.
40. Eisner MD, Iribarren C (2007) The influence of cigarette smoking on adult asthma outcomes. Nicotine Tob Res 9: 53-56.
41. Stevenson DD, Szczeklik A (2006) Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 118: 773-786; quiz 787- 778.
42. Berges-Gimeno MP, Simon RA, Stevenson DD (2002) The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 89: 474-478.
43. A. Szczeklik EN, M Duplaga (2000) Natural history of aspirin-induced asthma. Eur Respir J 16: 432-436.
44. Lotvall J, Akdis CA, Bacharier LB, Bjermer L, Casale TB, et al. (2011) Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol 127: 355-360.
45. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
46. Park HS, Kim SH, Sampson AP, Lee KW, Park CS (2004) The HLADPB1∗0301 marker might predict the requirement for leukotriene receptor antagonist in patients with aspirin-intolerant asthma. J Allergy Clin Immunol 114: 688-689.
47. Noguchi E, Sakamoto H, Hirota T, Ochiai K, Imoto Y, et al. (2011) Genomewide association study identifies HLA-DP as a susceptibility gene for pediatric asthma in Asian populations. PLoS Genet 7: e1002170.
48. Kim SH, Choi JH, Lee KW, Shin ES, Oh HB, et al. (2005) The human leucocyte antigen-DRB1∗1302-DQB1∗0609-DPB1∗0201 haplotype may be a strong genetic marker for aspirin-induced urticaria. Clin Exp Allergy 35: 339-344.
49. Schork NJ, Murray SS, Frazer KA, Topol EJ (2009) Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev 19: 212-219.
50. Dai S, Murphy GA, Crawford F, Mack DG, Falta MT, et al. (2010) Crystal structure of HLA-DP2 and implications for chronic beryllium disease. Proc Natl Acad Sci U S A 107: 7425-7430.
51. Birben E, Sackesen C, Kazani S, Tincer G, Karaaslan C, et al. (2011) The effects of an insertion in the 59UTR of the AMCase on gene expression and pulmonary functions. Respir Med 105: 1160-1169.
52. Spurr NK, Solomon E, Jansson M, Sheer D, Goodfellow PN, et al. (1984) Chromosomal localisation of the human homologues to the oncogenes erbA and B. EMBO J 3: 159-163.
53. Tee AR, Fingar DC, Manning BD, Kwiatkowski DJ, Cantley LC, et al. (2002) Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci U S A 99: 13571-13576.
54. Shin SW, Park J, Kim YJ, Uh ST, Choi BW, et al. (2012) A highly sensitive and specific genetic marker to diagnose aspirin-exacerbated respiratory disease using a genome-wide association study. DNA Cell Biol 31: 1604-1609.